Expanded Access Policy Strongbridge U.S. Inc. Policy on Expanded Access Strongbridge U.S. Inc. (Strongbridge) is a biopharmaceutical company committed to connecting patients with new treatments for rare diseases. As part of the drug development process, Strongbridge conducts clinical trials to study the safety and efficacy of its investigational products. The information from these trials is used to support marketing applications submitted to FDA and other regulatory authorities. Some drug companies may make their investigational drugs available to individual patients through an expanded access program. An expanded access program provides for the use of an investigational drug prior to approval by the FDA outside of the clinical trial setting. We believe the best way to make our investigational drugs available to individuals is through their participation in one of our ongoing clinical trials. For more information on Strongbridge’s clinical trials, see https://clinicaltrials.gov. If you are a healthcare professional and would like more information on Strongbridge’s investigational products, please contact expandedaccess@strongbridgebio.com. We anticipate that we will acknowledge receipt of emails within 5 business days. We reserve the right to revise this policy at any time. PRIVACY POLICY TERMS OF USE CONTACT US CAREERS For accessibility-related questions, comments, or concerns about this digital property, please email info@strongbridgebio.com and we will reply to your message. © 2021 Strongbridge Biopharma plc STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Dublin Limited and Strongbridge U.S. Inc. KEVEYIS® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc. MLR-0010 V21 06/2021 Ireland Address: Suite 206, Fitzwilliam Hall Fitzwilliam Place, Dublin 2, D02 T292 Ireland U.S. Address: 900 Northbrook Drive, Suite 200 Trevose, PA 19053 United States Phone: +1 610-254-9200 info@strongbridgebio.com Privacy Statement Compliance Program × This website intends to use cookies to improve the site and your experience. By continuing to browse this website, you are agreeing to accept our use of cookies. To learn more about our Privacy Statement, click here.